HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy
CD4+ T cells differentiate into various T helper subsets characterized by distinct cytokine secreting profiles that confer them effector functions adapted to a variety of infectious or endogenous threats. Regulatory CD4+ T cells are another specialized subset that plays a fundamental role in the mai...
Main Authors: | Alexandre Couture, Anthony Garnier, Fabian Docagne, Olivier Boyer, Denis Vivien, Brigitte Le-Mauff, Jean-Baptiste Latouche, Olivier Toutirais |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01081/full |
Similar Items
-
Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
by: Kathy Khoy, et al.
Published: (2020-09-01) -
Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy
by: Mohamad Hamieh, et al.
Published: (2021-09-01) -
Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
by: Pauline Hélie, et al.
Published: (2021-02-01) -
HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation
by: Sebastian Klobuch, et al.
Published: (2020-05-01) -
Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction
by: Wesley Huisman, et al.
Published: (2021-03-01)